Physician profile
Anthony T Arnott
NPI 1366612566
$475.64
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $279 · 2024: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $150.94 | 2023 | Hizentra |
| Takeda Pharmaceuticals U.S.A., INC. | $123.82 | 2023-2024 | Glassia, Cuvitru |
| Mylan Specialty L.P. | $46.68 | 2023 | Yupelri |
| Electromed, INC. | $38.65 | 2023-2024 | Smartvest |
| Exact Sciences Corporation | $37.59 | 2024 | Cologuard Collection Kit |
| Grifols USA, LLC | $34.94 | 2024 | Prolastin-C Liquid |
| Lilly USA, LLC | $24.15 | 2024 | Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $18.87 | 2024 | Breztri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Arnott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.